2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole

C238H154N10 — CID 167561227

IUPAC2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole
SMILESCc1ccc2c(-c3ccc4ccccc4c3)c3ccccc3c(-c3ccc(-c4nc5ccccc5n4-c4ccccc4)cc3)c2c1.c1ccc(-n2c(-c3c4ccccc4c(-c4c5ccccc5c(-c5ccc6ccccc6c5)c5ccccc45)c4ccccc34)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccc(-c4c5ccccc5c(-c5ccc6ccccc6c5)c5ccccc45)c4ccccc34)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccc4cc(-c5c6ccccc6c(-c6ccc7ccccc7c6)c6ccccc56)ccc4c3)nc3ccccc32)cc1.c1ccc(-n2c(-c3cccc(-c4cccc(-c5c6ccccc6c(-c6ccc7ccccc7c6)c6ccccc56)c4)c3)nc3ccccc32)cc1
InChIInChI=1S/C51H32N2.C49H32N2.2C47H30N2.C44H30N2/c1-2-18-36(19-3-1)53-46-29-15-14-28-45(46)52-51(53)50-43-26-12-10-24-41(43)49(42-25-11-13-27-44(42)50)48-39-22-8-6-20-37(39)47(38-21-7-9-23-40(38)48)35-31-30-33-16-4-5-17-34(33)32-35;1-2-20-40(21-3-1)51-46-27-11-10-26-45(46)50-49(51)39-19-13-17-36(32-39)35-16-12-18-37(31-35)47-41-22-6-8-24-43(41)48(44-25-9-7-23-42(44)47)38-29-28-33-14-4-5-15-34(33)30-38;1-2-14-38(15-3-1)49-44-21-11-10-20-43(44)48-47(49)37-27-24-33-29-36(26-23-34(33)30-37)46-41-18-8-6-16-39(41)45(40-17-7-9-19-42(40)46)35-25-22-31-12-4-5-13-32(31)28-35;1-2-16-34(17-3-1)49-44-25-13-12-24-43(44)48-47(49)42-29-28-41(35-18-6-7-19-36(35)42)46-39-22-10-8-20-37(39)45(38-21-9-11-23-40(38)46)33-27-26-31-14-4-5-15-32(31)30-33;1-29-19-26-38-39(27-29)42(36-15-7-8-16-37(36)43(38)34-25-20-30-11-5-6-12-33(30)28-34)31-21-23-32(24-22-31)44-45-40-17-9-10-18-41(40)46(44)35-13-3-2-4-14-35/h1-32H;1-32H;2*1-30H;2-28H,1H3
InChIKeyDRJRJVKSYCQABT-UHFFFAOYSA-N
MW3153.92 g/mol
LogP64.02
Rot. Bonds21

About 2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole

2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole (PubChem CID 167561227) has the molecular formula C238H154N10 and a molecular weight of 3153.92 g/mol. Its IUPAC name is 2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole.

Molecular Properties

Compound Name2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole
PubChem CID167561227
Molecular FormulaC238H154N10
Molecular Weight3153.92 g/mol
Exact Mass3151.24
IUPAC Name2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole
SMILESCc1ccc2c(-c3ccc4ccccc4c3)c3ccccc3c(-c3ccc(-c4nc5ccccc5n4-c4ccccc4)cc3)c2c1.c1ccc(-n2c(-c3c4ccccc4c(-c4c5ccccc5c(-c5ccc6ccccc6c5)c5ccccc45)c4ccccc34)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccc(-c4c5ccccc5c(-c5ccc6ccccc6c5)c5ccccc45)c4ccccc34)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccc4cc(-c5c6ccccc6c(-c6ccc7ccccc7c6)c6ccccc56)ccc4c3)nc3ccccc32)cc1.c1ccc(-n2c(-c3cccc(-c4cccc(-c5c6ccccc6c(-c6ccc7ccccc7c6)c6ccccc56)c4)c3)nc3ccccc32)cc1
InChIInChI=1S/C51H32N2.C49H32N2.2C47H30N2.C44H30N2/c1-2-18-36(19-3-1)53-46-29-15-14-28-45(46)52-51(53)50-43-26-12-10-24-41(43)49(42-25-11-13-27-44(42)50)48-39-22-8-6-20-37(39)47(38-21-7-9-23-40(38)48)35-31-30-33-16-4-5-17-34(33)32-35;1-2-20-40(21-3-1)51-46-27-11-10-26-45(46)50-49(51)39-19-13-17-36(32-39)35-16-12-18-37(31-35)47-41-22-6-8-24-43(41)48(44-25-9-7-23-42(44)47)38-29-28-33-14-4-5-15-34(33)30-38;1-2-14-38(15-3-1)49-44-21-11-10-20-43(44)48-47(49)37-27-24-33-29-36(26-23-34(33)30-37)46-41-18-8-6-16-39(41)45(40-17-7-9-19-42(40)46)35-25-22-31-12-4-5-13-32(31)28-35;1-2-16-34(17-3-1)49-44-25-13-12-24-43(44)48-47(49)42-29-28-41(35-18-6-7-19-36(35)42)46-39-22-10-8-20-37(39)45(38-21-9-11-23-40(38)46)33-27-26-31-14-4-5-15-32(31)30-33;1-29-19-26-38-39(27-29)42(36-15-7-8-16-37(36)43(38)34-25-20-30-11-5-6-12-33(30)28-34)31-21-23-32(24-22-31)44-45-40-17-9-10-18-41(40)46(44)35-13-3-2-4-14-35/h1-32H;1-32H;2*1-30H;2-28H,1H3
InChIKeyDRJRJVKSYCQABT-UHFFFAOYSA-N
XLogP64.02
TPSA89.10 Ų
H-Bond Donors
H-Bond Acceptors10
Rotatable Bonds21
Heavy Atoms248
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5003153.92
LogP ≤ 564.02
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Analyze 2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole?
The IUPAC name of 2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole (CID 167561227) is 2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole.
What is the SMILES notation for 2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole?
The canonical SMILES for 2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole is Cc1ccc2c(-c3ccc4ccccc4c3)c3ccccc3c(-c3ccc(-c4nc5ccccc5n4-c4ccccc4)cc3)c2c1.c1ccc(-n2c(-c3c4ccccc4c(-c4c5ccccc5c(-c5ccc6ccccc6c5)c5ccccc45)c4ccccc34)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccc(-c4c5ccccc5c(-c5ccc6ccccc6c5)c5ccccc45)c4ccccc34)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccc4cc(-c5c6ccccc6c(-c6ccc7ccccc7c6)c6ccccc56)ccc4c3)nc3ccccc32)cc1.c1ccc(-n2c(-c3cccc(-c4cccc(-c5c6ccccc6c(-c6ccc7ccccc7c6)c6ccccc56)c4)c3)nc3ccccc32)cc1.
What is the InChIKey of 2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole?
The InChIKey is DRJRJVKSYCQABT-UHFFFAOYSA-N. The full InChI is InChI=1S/C51H32N2.C49H32N2.2C47H30N2.C44H30N2/c1-2-18-36(19-3-1)53-46-29-15-14-28-45(46)52-51(53)50-43-26-12-10-24-41(43)49(42-25-11-13-27-44(42)50)48-39-22-8-6-20-37(39)47(38-21-7-9-23-40(38)48)35-31-30-33-16-4-5-17-34(33)32-35;1-2-20-40(21-3-1)51-46-27-11-10-26-45(46)50-49(51)39-19-13-17-36(32-39)35-16-12-18-37(31-35)47-41-22-6-8-24-43(41)48(44-25-9-7-23-42(44)47)38-29-28-33-14-4-5-15-34(33)30-38;1-2-14-38(15-3-1)49-44-21-11-10-20-43(44)48-47(49)37-27-24-33-29-36(26-23-34(33)30-37)46-41-18-8-6-16-39(41)45(40-17-7-9-19-42(40)46)35-25-22-31-12-4-5-13-32(31)28-35;1-2-16-34(17-3-1)49-44-25-13-12-24-43(44)48-47(49)42-29-28-41(35-18-6-7-19-36(35)42)46-39-22-10-8-20-37(39)45(38-21-9-11-23-40(38)46)33-27-26-31-14-4-5-15-32(31)30-33;1-29-19-26-38-39(27-29)42(36-15-7-8-16-37(36)43(38)34-25-20-30-11-5-6-12-33(30)28-34)31-21-23-32(24-22-31)44-45-40-17-9-10-18-41(40)46(44)35-13-3-2-4-14-35/h1-32H;1-32H;2*1-30H;2-28H,1H3.
What are the key properties of 2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole?
2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole has a molecular weight of 3153.92 g/mol, XLogP of 64.02, 21 rotatable bonds, 0 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-(2-methyl-10-naphthalen-2-ylanthracen-9-yl)phenyl]-1-phenylbenzimidazole;2-[10-(10-naphthalen-2-ylanthracen-9-yl)anthracen-9-yl]-1-phenylbenzimidazole;2-[4-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]-1-phenylbenzimidazole;2-[6-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-2-yl]-1-phenylbenzimidazole;2-[3-[3-(10-naphthalen-2-ylanthracen-9-yl)phenyl]phenyl]-1-phenylbenzimidazole is sourced from PubChem (CID 167561227), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).